Skip to main content

Table 1 Patient Characteristics

From: Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure

Characteristic

Average (± SD)

Age (yrs)

52 (± 17)

Sex (male/female)

8/2

Ejection Fraction (%)

16% (± 8.18)

Ischemic/Non Ischemic etiology(%)

3 (30%)/7 (70%)

Beta adrenergic antagonist

9 (90%)

Angiotensin converting enzyme inhibitor or angiotensin receptor blocker

3 (30%)

Furosemide

8 (80%)

Furosemide continuous infusion

2 (20%)

Creatinine (mg/dL)

1.73 (± 0.83)

BNP (ng/ml)

803 (± 630)

Pulmonary capillary wedge pressure, baseline (mmHg)

30 (± 8.5)

Pulmonary capillary wedge pressure, @ 24 hours (mmHg)

23 (± 5.0)

Cardiac Index, baseline (L/min/m2)

1.81 (± 0.63)

Cardiac Index @ 24 hours (L/min/m2)

2.51 (± 0.74)